When it comes to exporting dietary supplements to the European Union, one of the most common reasons Chinese manufacturers lose business — or worse, face regulatory action — is improper use of health claims. The European Food Safety Authority (EFSA) maintains the strictest health claim regime in the world. Failing to navigate it correctly can …
When it comes to exporting dietary supplements to the European Union, one of the most common reasons Chinese manufacturers lose business — or worse, face regulatory action — is improper use of health claims. The European Food Safety Authority (EFSA) maintains the strictest health claim regime in the world. Failing to navigate it correctly can mean rejected product applications, import bans, and reputational damage that reaches far beyond a single shipment.
This guide breaks down what every OEM/ODM supplement manufacturer targeting the EU market needs to know.
## What Are EFSA Health Claims?
Under Regulation (EC) No 1924/2006, any claim made on a food or supplement label — in marketing materials, on packaging, or in digital content — that states, implies, or suggests a relationship between a food and health must be substantiated according to EFSA standards.
Health claims fall into three categories:
– **Health claims (general):** Link a food/nutrient to health (e.g., “Calcium supports bone health”)
– **Article 13.5 claims:** Novel health claims based on newly developed scientific evidence
– **Article 14 claims:** Reduction of disease risk claims and claims about children’s development
The EU maintains two positive lists — one for nutrient profiles (still not fully implemented) and one for authorized health claims. Only claims on these lists are legally permitted.
## Why So Many Claims Get Rejected
EFSA’s Scientific Panel on Dietetic Products, Nutrition and Allergies (NDA Panel) evaluates health claims against criteria in Article 13(1) and 14 of the Regulation. The most common reasons for rejection include:
1. **Insufficient human studies** — Animal or in vitro data is not accepted. You need human intervention studies demonstrating cause-and-effect.
2. **Poor study design** — Studies must be of high quality, with appropriate endpoints, sample sizes, and duration.
3. **Characterization issues** — EFSA must be able to characterize the food/constituent being studied. If they can’t define exactly what was used in the study, the claim fails.
4. **Generic extrapolation not accepted** — You cannot extrapolate from one substance to another, even if chemically related.
5. **Dosage confusion** — Studies must reflect the quantities typically consumed in a normal diet or the proposed supplement dose.
## What Chinese Manufacturers Can Do
### 1. Work with Clients to Verify Claim Eligibility Before Formulation
The biggest mistake is building a formula and then figuring out the claims. Instead, work backwards:
– Identify the target EU market countries
– Review EFSA’s positive list for relevant claims
– Match claims to ingredients with sufficient substantiation
– Only then finalize the formula
This saves enormous cost and prevents reformulation later.
### 2. Use Well-Characterized, Documented Ingredients
EFSA scrutinizes not just the claim but the ingredient itself. For each raw material:
– Obtain full specification sheets (COA, heavy metal profiles, microbiological data)
– Use materials with published human clinical data
– Ensure the ingredient used in studies matches what’s in your product (same source, same extract ratio, same specification)
– Keep third-party testing reports ready
For botanical extracts especially, EFSA requires precise characterization of the plant part, extraction solvent, and standardization markers.
### 3. Avoid Disease Risk Reduction Claims
Article 14 claims (“reduces risk of heart disease,” “may reduce cancer risk”) are among the most strictly regulated. These are essentially prohibited for supplements unless individually authorized by the European Commission — an extremely rare event.
Train your clients: if they want to communicate cardiovascular, metabolic, or cognitive health benefits, use structure-function claims with EFSA-compliant wording, not disease risk language.
### 4. Prepare a Robust Claims Dossier
When submitting a health claim for EFSA evaluation (Article 13.5 or Article 14 route), the dossier must include:
– Systematic review of human studies
– Study methodology details (blinding, randomization, duration, endpoints)
– Statistical analysis
– Relevance to the EU population
– Proposed wordings that reflect the evidence
Many Chinese manufacturers partner with EU-based regulatory consultancies to compile these dossiers, which can cost EUR 30,000-EUR 150,000+ depending on complexity.
### 5. Label Design Review Is Non-Negotiable
Even if your formula is clean, improper label language can trigger EU market withdrawal. Common issues:
– Unauthorized health claims in the supplement facts box
– Unsubstantiated claims on the back label
– Claims on inner packaging that aren’t visible at point of sale but appear in e-commerce listings
– “Green” or “free from” claims that violate Regulation 1924/2006
– Missing mandatory statements
We strongly recommend EU-market labels go through regulatory review before printing — a EUR 500 label review saves a EUR 50,000 recall.
## The Bottom Line for OEM/ODM Partners
If you are a contract manufacturer working with brands targeting the EU, your role in compliance extends far beyond making capsules. You must be a partner in:
– **Ingredient selection** — sourcing materials with EFSA-acceptable dossiers
– **Dossier preparation support** — providing specifications, CoAs, and testing data
– **Label review** — flagging non-compliant claim language before production
– **GMP documentation** — maintaining batch records traceable to EU import requirements
Manufacturers who can demonstrate a structured EU compliance process — not just cheap pricing — are the partners European brands are actively seeking.
—
**Ready to work with an EU-ready supplement manufacturer?**
Contact us today to discuss your formula, target markets, and compliance requirements.
Email: Wade@zuoningbio.com | Phone: +86 187 5469 6289 | Website: www.zuoningbio.com
*We specialize in OEM/ODM manufacturing for dietary supplements, with extensive experience supporting clients targeting the EU, US, and Asia-Pacific markets.*
